<DOC>
	<DOC>NCT00080054</DOC>
	<brief_summary>The purpose of this study is to find out about the safety of adding the investigational drug motexafin gadolinium to a standard course of chemotherapy with temozolomide for patients with malignant glioma. Secondly, the study will determine how many patients will respond to this treatment.</brief_summary>
	<brief_title>A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<mesh_term>Oligodendroglioma</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Motexafin gadolinium</mesh_term>
	<criteria>At least 18 years old Histologically confirmed diagnosis of malignant gliomas that requires systemic antineoplastic treatment. Malignant glioma is defined as any of the following: Glioblastoma multiforme (GBM); Anaplastic astrocytoma (AA); Anaplastic oligodendroglioma; Anaplastic mixed glioma; Glioma not otherwise specified (except lowgrade glioma) ECOG performance status score of 0, 1, or 2 Each patient must sign a studyspecific informed consent form Laboratory values of: Absolute neutrophil count &lt; 2000/µL Platelet count &lt; 100,000/µL AST or ALT &gt; 2 x the upper limit of normal (ULN) Alkaline phosphatase &gt; 5 x ULN Bilirubin &gt; 2 x ULN Creatinine &gt; 2.0 mg/µL and Plan to use any additional cancer therapy (e.g., systemic, radiation, surgery) during the study period Women who are pregnant or lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>Malignant Glioma</keyword>
	<keyword>Glioblastoma multiforme</keyword>
	<keyword>GBM</keyword>
	<keyword>Anaplastic astrocytoma</keyword>
	<keyword>AA</keyword>
	<keyword>Anaplastic oligodendroglioma</keyword>
	<keyword>Anaplastic mixed glioma</keyword>
	<keyword>Brain tumor</keyword>
	<keyword>Brain neoplasm</keyword>
	<keyword>Glioma</keyword>
</DOC>